11286 related articles for article (PubMed ID: 10950155)
1. Human CD8 and CD4 T cell epitopes of epithelial cancer antigens.
Sato N; Nabeta Y; Kondo H; Sahara H; Hirohashi Y; Kashiwagi K; Kanaseki T; Sato Y; Rong S; Hirai I; Kamiguchi K; Tamura Y; Matsuura A; Takahashi S; Torigoe T; Ikeda H
Cancer Chemother Pharmacol; 2000; 46 Suppl():S86-90. PubMed ID: 10950155
[TBL] [Abstract][Full Text] [Related]
2. Identification of natural antigenic peptides of a human gastric signet ring cell carcinoma recognized by HLA-A31-restricted cytotoxic T lymphocytes.
Suzuki K; Sahara H; Okada Y; Yasoshima T; Hirohashi Y; Nabeta Y; Hirai I; Torigoe T; Takahashi S; Matsuura A; Takahashi N; Sasaki A; Suzuki M; Hamuro J; Ikeda H; Wada Y; Hirata K; Kikuchi K; Sato N
J Immunol; 1999 Sep; 163(5):2783-91. PubMed ID: 10453022
[TBL] [Abstract][Full Text] [Related]
3. Induction of cytotoxic T lymphocytes from peripheral blood of human histocompatibility antigen (HLA)-A31(+) gastric cancer patients by in vitro stimulation with antigenic peptide of signet ring cell carcinoma.
Nabeta Y; Sahara H; Suzuki K; Kondo H; Nagata M; Hirohashi Y; Sato Y; Wada Y; Sato T; Wada T; Yamashita T; Kikuchi K; Sato N
Jpn J Cancer Res; 2000 Jun; 91(6):616-21. PubMed ID: 10874214
[TBL] [Abstract][Full Text] [Related]
4. A gene encoding human gastric signet ring cell carcinoma antigen recognized by HLA-A31-restricted cytotoxic T lymphocytes.
Sahara H; Nabeta Y; Torigoe T; Hirohashi Y; Ichimiya S; Wada Y; Takahashi N; Jimbow K; Yajima T; Watanabe N; Kikuchi K; Sato N
J Immunother; 2002; 25(3):235-42. PubMed ID: 12000865
[TBL] [Abstract][Full Text] [Related]
5. The mechanism of human autologous gastric signet ring cell tumor rejection by cytotoxic T lymphocytes in the possible context of HLA-A31 molecule.
Yasoshima T; Sato N; Hirata K; Kikuchi K
Cancer; 1995 Mar; 75(6 Suppl):1484-9. PubMed ID: 7889479
[TBL] [Abstract][Full Text] [Related]
6. Natural antigenic peptides from squamous cell carcinoma recognized by autologous HLA-DR8-restricted CD4+ T cells.
Kondo H; Sahara H; Miyazaki A; Nabeta Y; Hirohashi Y; Kanaseki T; Yamaguchi A; Yamada N; Hirayama K; Suzuki M; Hamuro J; Torigoe T; Takahashi N; Kohama GI; Ikeda H; Sato N
Jpn J Cancer Res; 2002 Aug; 93(8):917-24. PubMed ID: 12716470
[TBL] [Abstract][Full Text] [Related]
7. NY-ESO-1 encodes DRB1*0401-restricted epitopes recognized by melanoma-reactive CD4+ T cells.
Zarour HM; Storkus WJ; Brusic V; Williams E; Kirkwood JM
Cancer Res; 2000 Sep; 60(17):4946-52. PubMed ID: 10987311
[TBL] [Abstract][Full Text] [Related]
8. Cytotoxicity of histocompatibility leukocyte antigen-DR8-restricted CD4 killer T cells against human autologous squamous cell carcinoma.
Miyazaki A; Sato N; Takahashi S; Sasaki A; Kohama G; Yamaguchi A; Yagihashi A; Kikuchi K
Jpn J Cancer Res; 1997 Feb; 88(2):191-7. PubMed ID: 9119748
[TBL] [Abstract][Full Text] [Related]
9. Immediate early response gene X-1, a stress-inducible antiapoptotic gene, encodes cytotoxic T-lymphocyte (CTL) epitopes capable of inducing human leukocyte antigen-A33-restricted and tumor-reactive CTLs in gastric cancer patients.
Sasada T; Takedatsu H; Azuma K; Koga M; Maeda Y; Shichijo S; Shoumura H; Hirai T; Takabayashi A; Itoh K
Cancer Res; 2004 Apr; 64(8):2882-8. PubMed ID: 15087407
[TBL] [Abstract][Full Text] [Related]
10. A newly identified MAGE-3-derived epitope recognized by HLA-A24-restricted cytotoxic T lymphocytes.
Oiso M; Eura M; Katsura F; Takiguchi M; Sobao Y; Masuyama K; Nakashima M; Itoh K; Ishikawa T
Int J Cancer; 1999 May; 81(3):387-94. PubMed ID: 10209953
[TBL] [Abstract][Full Text] [Related]
11. Identification of multiple HLA-DR-restricted epitopes of the tumor-associated antigen CAMEL by CD4+ Th1/Th2 lymphocytes.
Slager EH; van der Minne CE; Krüse M; Krueger DD; Griffioen M; Osanto S
J Immunol; 2004 Apr; 172(8):5095-102. PubMed ID: 15067093
[TBL] [Abstract][Full Text] [Related]
12. A cyclophilin B gene encodes antigenic epitopes recognized by HLA-A24-restricted and tumor-specific CTLs.
Gomi S; Nakao M; Niiya F; Imamura Y; Kawano K; Nishizaka S; Hayashi A; Sobao Y; Oizumi K; Itoh K
J Immunol; 1999 Nov; 163(9):4994-5004. PubMed ID: 10528204
[TBL] [Abstract][Full Text] [Related]
13. HLA-DRB1*0410-restricted recognition of XAGE-1b37-48 peptide by CD4 T cells.
Morishita Y; Uenaka A; Kaya S; Sato S; Aji T; Nakayama E
Microbiol Immunol; 2007; 51(8):755-62. PubMed ID: 17704638
[TBL] [Abstract][Full Text] [Related]
14. Generation of stable CD4+ and CD8+ T cell lines from patients immunized with ras oncogene-derived peptides reflecting codon 12 mutations.
Abrams SI; Khleif SN; Bergmann-Leitner ES; Kantor JA; Chung Y; Hamilton JM; Schlom J
Cell Immunol; 1997 Dec; 182(2):137-51. PubMed ID: 9514698
[TBL] [Abstract][Full Text] [Related]
15. Screening of HLA-A24-restricted epitope peptides from prostate-specific membrane antigen that induce specific antitumor cytotoxic T lymphocytes.
Horiguchi Y; Nukaya I; Okazawa K; Kawashima I; Fikes J; Sette A; Tachibana M; Takesako K; Murai M
Clin Cancer Res; 2002 Dec; 8(12):3885-92. PubMed ID: 12473604
[TBL] [Abstract][Full Text] [Related]
16. Melan-A/MART-1-specific CD4 T cells in melanoma patients: identification of new epitopes and ex vivo visualization of specific T cells by MHC class II tetramers.
Bioley G; Jandus C; Tuyaerts S; Rimoldi D; Kwok WW; Speiser DE; Tiercy JM; Thielemans K; Cerottini JC; Romero P
J Immunol; 2006 Nov; 177(10):6769-79. PubMed ID: 17082590
[TBL] [Abstract][Full Text] [Related]
17. Generation of NY-ESO-1-specific CD4+ and CD8+ T cells by a single peptide with dual MHC class I and class II specificities: a new strategy for vaccine design.
Zeng G; Li Y; El-Gamil M; Sidney J; Sette A; Wang RF; Rosenberg SA; Robbins PF
Cancer Res; 2002 Jul; 62(13):3630-5. PubMed ID: 12097265
[TBL] [Abstract][Full Text] [Related]
18. A HER2/NEU-derived peptide, a K(d)-restricted murine tumor rejection antigen, induces HER2-specific HLA-A2402-restricted CD8(+) cytotoxic T lymphocytes.
Ikuta Y; Okugawa T; Furugen R; Nagata Y; Takahashi Y; Wang L; Ikeda H; Watanabe M; Imai S; Shiku H
Int J Cancer; 2000 Aug; 87(4):553-8. PubMed ID: 10918197
[TBL] [Abstract][Full Text] [Related]
19. One NY-ESO-1-derived epitope that promiscuously binds to multiple HLA-DR and HLA-DP4 molecules and stimulates autologous CD4+ T cells from patients with NY-ESO-1-expressing melanoma.
Mandic M; Castelli F; Janjic B; Almunia C; Andrade P; Gillet D; Brusic V; Kirkwood JM; Maillere B; Zarour HM
J Immunol; 2005 Feb; 174(3):1751-9. PubMed ID: 15661941
[TBL] [Abstract][Full Text] [Related]
20. Identification of a tumor-specific shared antigen derived from an Eph receptor and presented to CD4 T cells on HLA class II molecules.
Chiari R; Hames G; Stroobant V; Texier C; Maillère B; Boon T; Coulie PG
Cancer Res; 2000 Sep; 60(17):4855-63. PubMed ID: 10987298
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
